Abstract
The usual treatment for ameloblastic carcinoma is surgical resection. The effectiveness of radiotherapy and chemotherapy for the disease has not been determined, and few effective treatments are available for local recurrence and distant metastasis. Recently, molecular targeting using BRAFV600E inhibitors has attracted interest as a treatment for ameloblastoma and ameloblastic carcinoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Japanese Journal of Oral and Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
